MGB Biopharma Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:MGB Biopharma Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014168
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MGB Biopharma Ltd (MGB) is a clinical stage biopharmaceutical company which develops anti-infective medicine of minor groove binder (MGBs) compounds. The company focuses on the development of new class of small molecules, with specific antibacterial activity against susceptible and resistant bacteria. It offers its lead drug candidate, MGB-BP-3 in the field of antibacterial resistance. The company provides programmes which include Oral, gram-positive IV, topical, gram negative, anti-fungal, anti-viral, anti-parasitic. It provides anti-infective platform solutions to deliver drugs against multi-resistant Gram-negative pathogens, viruses, fungi and parasitic diseases. The company seeks to work in partnership with research institutes and pharmaceutical companies in the antibiotics field.MGB is headquartered in Glasgow, the UK.

MGB Biopharma Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MGB Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MGB Biopharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MGB Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MGB Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
MGB Biopharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
MGB Biopharma Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
MGB Biopharma Raises USD1.2 Million in Venture Financing 10
MGB Biopharma Raises USD4.4 Million in Venture Financing 11
MGB Biopharma Raises US$1 Million In Venture Financing 12
MGB Biopharma Raises US$1.2 Million In Venture Financing 14
Partnerships 15
MGB Biopharma Enters into Agreement with University of Strathclyde 15
MGB Biopharma Ltd – Key Competitors 16
MGB Biopharma Ltd – Key Employees 17
MGB Biopharma Ltd – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Product News 19
05/19/2016: MGB Biopharma Welcomes Jim O Neill Final Recommendations for the World to Defeat Superbugs 19
Product Approvals 20
May 09, 2016: MGB Biopharma’s Pre-IND Meeting with FDA Provides Clear Guidelines on Further Development of Oral MGB-BP-3, a Truly Novel Antibiotic Targeting Clostridium difficile Infections 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
MGB Biopharma Ltd, Pharmaceuticals & Healthcare, Key Facts 2
MGB Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MGB Biopharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MGB Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MGB Biopharma Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
MGB Biopharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
MGB Biopharma Raises USD1.2 Million in Venture Financing 10
MGB Biopharma Raises USD4.4 Million in Venture Financing 11
MGB Biopharma Raises US$1 Million In Venture Financing 12
MGB Biopharma Raises US$1.2 Million In Venture Financing 14
MGB Biopharma Enters into Agreement with University of Strathclyde 15
MGB Biopharma Ltd, Key Competitors 16
MGB Biopharma Ltd, Key Employees 17

★海外企業調査レポート[MGB Biopharma Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Targa Resources Corp (TRGP):企業の財務・戦略的SWOT分析
    Targa Resources Corp (TRGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Medifast Inc (MED):企業の財務・戦略的SWOT分析
    Medifast Inc (MED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • LivaNova PLC (LIVN):製品パイプライン分析
    Summary LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery, neuromodulation and cardiac rhythm management. The company’s neuromodulation segment provides vagus nerve stimulation therapy system, an implantable device for the people affected by trea …
  • Human Longevity Inc-製薬・医療分野:企業M&A・提携分析
    Summary Human Longevity Inc (HLI) is a genomics-based, technology-driven company which develops database of whole genome, phenotype and clinical data. Its discovery capabilities include streamlining drug development, rescuing and repurposing drugs from failed clinical trials and discovery of biomark …
  • L’Oreal SA:戦略・SWOT・企業財務分析
    L'Oreal SA - Strategy, SWOT and Corporate Finance Report Summary L'Oreal SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Central Glass Co Ltd (4044):企業の財務・戦略的SWOT分析
    Central Glass Co Ltd (4044) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Central Bank of Egypt:企業の戦略的SWOT分析
    Central Bank of Egypt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Cogeco Inc:企業の戦略・SWOT・財務情報
    Cogeco Inc - Strategy, SWOT and Corporate Finance Report Summary Cogeco Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • freenet AG:企業のM&A・事業提携・投資動向
    freenet AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's freenet AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Schaffer Corporation Limited (SFC):企業の財務・戦略的SWOT分析
    Schaffer Corporation Limited (SFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Vizrt Group AS.:企業の戦略的SWOT分析
    Vizrt Group AS. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Schmolz + Bickenbach AG:企業の戦略・SWOT・財務情報
    Schmolz + Bickenbach AG - Strategy, SWOT and Corporate Finance Report Summary Schmolz + Bickenbach AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Performance Food Group:企業の戦略・SWOT・財務分析
    Performance Food Group - Strategy, SWOT and Corporate Finance Report Summary Performance Food Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • University of Aberdeen:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Aberdeen (UOA) is an educational and research institution that offers educational and research programs. The university offers undergraduate, graduate, postgraduate and research programs. It provides undergraduate and postgraduate courses in the areas of education, creative art …
  • Al Arrab Contracting Company:企業の戦略的SWOT分析
    Al Arrab Contracting Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Compass Group PLC:戦略・SWOT・企業財務分析
    Compass Group PLC - Strategy, SWOT and Corporate Finance Report Summary Compass Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Vericel Corp (VCEL):企業の財務・戦略的SWOT分析
    Vericel Corp (VCEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Robert Half International Inc (RHI):企業の財務・戦略的SWOT分析
    Robert Half International Inc (RHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Air Transport Services Group, Inc.:企業の戦略・SWOT・財務情報
    Air Transport Services Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Air Transport Services Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Paladin Energy Ltd.:企業の戦略的SWOT分析
    Paladin Energy Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆